Researchers discover how chronic lymphocytic leukemia cells evade treatment by switching survival signals
A new study published in Blood Journal reveals that chronic lymphocytic leukemia (CLL) cells can switch between different survival signals to evade treatment, helping explain why therapies work for some patients but develop resistance in others. The research identifies how cancer cells alternate between low and high basal signaling states through TLR9 activation.
